Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms
{{output}}
Background: Cannabis is increasingly available worldwide but its impact on cognition in Parkinson's disease (PD) is unknown. Objective: Present... ...
